Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116961062 | 11696106 | 2 | F | 201401 | 20160822 | 20151104 | 20160830 | EXP | US-JNJFOC-20151100044 | JANSSEN | 56.33 | YR | A | F | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116961062 | 11696106 | 1 | PS | INVOKANA | CANAGLIFLOZIN | 1 | Oral | U | U | 204042 | 300 | MG | TABLET | ||||||
| 116961062 | 11696106 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 0 | 1000 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116961062 | 11696106 | 1 | Diabetes mellitus |
| 116961062 | 11696106 | 2 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116961062 | 11696106 | HO |
| 116961062 | 11696106 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116961062 | 11696106 | Acute kidney injury | |
| 116961062 | 11696106 | Diabetic ketoacidosis | |
| 116961062 | 11696106 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |